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Abstract A novel strategy, which employs a cytochrome bo-
lacking strain (GO104) and a modified isolation procedure 
provides an effective approach for obtaining much purer 
preparations of ECFiF0 than described previously, as well as 
for isolating homogeneous and protein-chemically pure ECF^ 
ECFi obtained in this way could be crystallized by vapor-
diffusion using polyethylene glycol (PEG) as a precipitant in a 
form suitable for X-ray diffraction analysis. The crystals belong 
to the orthorhombic space group P2i2j2i, with lattice pa-
rameters a = 110, 6 = 134, and c = 269 A, and diffract to a 
resolution of at least 6.4 A. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
FiF0 type ATPases or ATP synthases catalyze oxidative or 
photo-phosphorylation by using a transmembrane proton-
motive force to drive ATP synthesis. In the reverse direction, 
these enzymes use ATP to generate a proton gradient that can 
be used in ion transport processes. They are large, multisub-
unit complexes. For example, the Escherichia coli enzyme 
ECFiFo is composed of 8 different subunits. Five of these, 
the a, (3, y, 8 and e subunits are present in the stoichiometry 
3:3:1:1:1, respectively, and form the membrane extrinsic Fi 
part which contains the (three) catalytic sites. The other three 
different subunits, a, b and c in the molar ratio 1:2:9—12, form 
the membrane bilayer intercalated F0 part which includes the 
proton pore. The entire complex has a molecular weight of 
approximately 530000 [1-4]. 
A major advance in our understanding of these complex 
enzymes has come with the crystallization of MFi and a struc-
ture determination of the (X3P3 domain and part of the y sub-
unit at 2.8 A resolution [5,6]. So far, there has been limited 
success in crystallizing enzyme from bacterial sources. The 
only report of such crystals is of a preparation reconstituted 
from a and P subunits (013P3) from TFi [7]. High resolution 
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structural data for the isolated 8 and e subunits of ECFi have 
been obtained in our laboratory by NMR [8,9]. However, 
until recently we (and others) have failed to obtain X-ray 
diffraction quality crystals of either ECFi or ECFiF0, despite 
prolonged efforts. 
A serious problem has been that preparations contain low 
but significant amounts of impurities, and are not homoge-
nous. Therefore, we have looked for improved ways of puri-
fying ECFi and ECFiF0 . We were aware that a major im-
purity of E C F I F Q was cytochrome bo under the conditions of 
relatively high aeration at which we grow E. coli for large-
scale purification of the enzyme complex. Therefore, we have 
examined isolation of both ECFi and ECFiF0 from cyto-
chrome 60-deficient strains of E. coli. This novel genetic re-
moval of impurities has allowed us to obtain highly pure 
ECFi and E C F I F Q , which should be useful for a range of 
biochemical and biophysical studies. As we show for ECFi, 
these preparations are pure and homogenous enough that 
crystals of the enzymes can now be obtained. 
2. Materials and methods 
2.1. Purification of ECFi 
E. coli cells (100 g) were resuspended in 150 ml of 200 mM Tris, pH 
8.0 and 1 mM EDTA added prior to dilution with a further 150 ml of 
buffer containing 200 mM Tris, pH 8.0, 1 M sucrose and 60 mg 
lysozyme. The suspension was stirred for 20 min at room temperature, 
and then 300 ml distilled water, 5 mg DNase I and 50 mM MgCl2 
added with subsequent stirring for 20 min at 4°C. After centrifugation 
(11 000 Xg, 15 min), the pellet was resuspended in 450 ml of 0.1 M 
TES, pH 7.0, 20 mM Mg(C2H302)2, 0.25 M Sucrose, 0.25 mM 
EGTA and 40 mM EACA, and 5 mM PAB, 1 mM DTE, 1 mM 
PMSF, 5 mg DNase I added before disruption of cells using a French 
pressure cell press. The suspension after French pressing was centri-
fuged at 165000Xg for 2 h. The pellet containing the membranes was 
washed three times in 400 ml of 50 mM TES, pH 7.0, 15% (v/v) 
glycerol, 40 mM EACA, 6 mM PAB (buffer A) and subsequently in 
modified buffer A with 5 mM TES with centrifugation at 165000Xg 
for 90 min after each wash. 
Detachment and precipitation of the ECF] was carried out accord-
ing to Senior et al. [10], using PEG 8000 as a precipitant. After 
centrifugation of the precipitated enzyme (13 200Xg, 1 h) the pellet 
was dissolved in 74 ml buffer B (50 mM Tris, pH 7.4, 20% (v/v) 
glycerol, 2 mM EDTA, 1 mM ATP, 1 mM DTT, 40 mM EACA 
and 1 mM PMSF) and centrifuged at 39200Xg for 15 min. The pellet 
was resuspended in buffer B with the addition of 0.2 M NaCl and 
stirred for 1 h before loading onto a DEAE Sepharose CL-6B-200 
column. The column-bound protein was washed with the same buffer 
before eluting with 0.8 M NaCl at a flow rate of 0.6 ml/min. The peak 
of enzyme, as determined by ATPase activity, was pooled and pre-
cipitated with 70% (NH4)2S04, then applied to a Sephacryl S-300-HR 
column, according to Gogol et al. [11]. Enzyme eluting from this 
column was located by enzyme activity, precipitated for 1 h in 70% 
(NFt4)2S04, centrifuged at 15000Xg for 20 min and then dissolved in 
50 mM MOPS, pH 7.0, 0.5 mM EDTA and 10% glycerol (v/v). 
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B made with 30 (ig aliquots of ECFi (15 mg/ml) denatured with 10 u.1 of 14% perchloric acid. Samples were centrifuged at 5000 rpm for 
2 min, neutralized with 6 u,g of 5 M K2CO3, and then incubated at 
4°C for 15 min before centrifugation at 5000 rpm for 2 min [12]. 
Nucleotide content of the supernatant was determined by HLPC using 
a Brownlee C-18 (Spheri-5) reversed-phase column eluted with 50 mM 
KH2PO4, pH 5.0, 2.5 mM tetrabutylammonium phosphate at a flow 
rate of 1 ml/min at 35°C. The relationship between the integrated 
peak area and nucleotide amounts was determined from nucleotide 
standards of known concentration. After this treatment, it was found 
that ECFi preparations retained 0.1-0.3 mol of ATP per mole en-
zyme. 
Fig. 1. SDS polyacrylamide gel electrophoresis of ECFiF0 and 
ECFi. (A) 35 ug [4 mg/ml] of ECFiF0 and (B) 60 \ig of ECFi [20 
mg/ml] were separated by a 16-22% and 10-18% linear gradient 
SDS-PAGE, respectively. The gels were stained with Coomassie 
Brilliant Blue R. 
2.2. Removal of bound nucleotides for crystallization of ECFi 
ECFi isolated as described above is heterogeneous with respect to 
the nucleotide content of both catalytic and non-catalytic sites. Thus, 
bound nucleotides were removed by passing enzyme samples through 
three consecutive Sephadex G-50 centrifuge columns in the MOPS 
buffer described above. Analysis of residual bound nucleotide was 
2.3. Crystallization conditions for ECFi 
Purified and nucleotide-depleted ECFi concentrated to 10 mg/ml 
using Amicon Centron 100 concentrators was used in crystallization 
experiments. Crystals were grown by the hanging drop vapor diffusion 
method [13] at 20°C. Each drop consisted of 4 (xl of well solution 
containing 25% PEG 400, 0.1 M HEPES, pH 7.0, 3 mM MgCl2, 75 
|a.M AMP-PNP and 1.5 uM ADP. Crystals were mounted in tapered 
glass capillaries according to Abrahams and Leslie [14]. X-ray data 
were collected on a R-AXIS lie imaging plate area detector using Cu 
K a radiation generated by a Rigaku RU 300 rotating anode, operat-
ing at 40 kV and 100 mA. The crystal-to-imaging plate distance was 
450 mm, and the collimator size, 0.7 mm. Oscillations of 1° per 120 
mm were used. R-AXIS data were processed with DENZO [15]. 
2.4. Other methods 
Subunit compositions of ECFi and ECF1F0 preparations were an-
alyzed using SDS containing polyacrylamide gradient gels, according 
to Laemmli [16], Gels were stained with Coomassie Brilliant Blue R as 
described by Downer et al. [17]. Protein concentrations were deter-
mined with the BCA assay system from Pierce Chemical Co. 
3. Results and discussion 
Preparations of ECFiF0 have traditionally been made from 
strains of E. coli such as AN1460 [18], AN888 [19] and RF-7 
Fig. 2. Crystal of ECFi. The crystal has approximately dimensions of 0.5x0.4x0.2 mm. 
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Fig. 3. A 1° oscillation image of crystals of ECFi. The image was 
recorded on an R-AXIS He imaging-plate area detector, with an ex-
posure time of 120 min. Reflections at the extreme right and ex-
treme left of the image correspond to a resolution of 5.4 A. 
[20] that contain the unc operon on an overexpressing plas-
mid. Our best preparations of enzyme from these strains al-
ways contain impurities that can be clearly observed even at 
low protein loading of SDS polyacrylamide gels. These prep-
arations often appear slightly brown and spectral analyses 
show the presence of cytochrome bo. Therefore, to improve 
the purification of ECFiFo, we decided to isolate the enzyme 
from a strain of E. coli that was unable to make this cyto-
chrome. Thus, the wMc-containing plasmid, pAN45 [18], was 
introduced into the E. coli strain GO 104 which has cyto-
chrome bo genetically deleted [21]. Fig. 1A presents a 16-
22% gradient (SDS) polyacrylamide gel of a typical prepara-
tion of enzyme from this strain, purified by the standard 
technique of Foster and Fillingame [20], and shown here after 
the sucrose gradient step and before reconstitution with added 
lipids, which itself improves purity to a small extent. The 
preparation is considerably more pure than our best prepara-
tions of enzyme using previous strains (see, for example, figs. 
4 and 2, respectively, in Aggeler and Capaldi, 1995 [22]; Watts 
et al., 1996 [23] and Fig. 1A and C and Fig. 2, respectively 
[24-26], for preparations from other laboratories). Subsequent 
ion exchange chromatography steps have recently yielded an 
E C F I F Q preparation from which 3D crystals have been ob-
tained. On preliminary analysis these diffract to at least 10 A, 
as will be described in detail elsewhere. 
Surprisingly, the use of this strain also yielded improved 
preparations of ECFi as evident in Fig. IB, which shows a 
Coomassie blue-stained SDS polyacrylamide gel loaded with 
60 |j.g of enzyme. The degradation product of 8 subunit often 
seen in ECFi preparations running slightly above the E sub-
unit, is not seen in these new preparations. Other minor im-
purities often resolved on gels when equally heavily loaded are 
also not seen. Moreover, the molar ratio of y, 8 and e subunits 
appears to be 1:1:1, based on a quantitation of the staining 
intensity of the three bands of these subunits, respectively 
(result not shown). Additional evidence that the e subunit is 
in stoichiometric amounts comes from activity measurements. 
The e subunit is an inhibitor of the ATPase activity of ECFi. 
In most preparations, addition of exogenous e subunit reduces 
ATPase activity, indicating that a fraction of enzyme mole-
cules are devoid of e subunit, or that this subunit is shifted 
from its inhibitor site. However, ECFi from strain GO 104 has 
relatively low ATP hydrolysis rates as isolated (10 nmol ATP 
hydrolyzed mg - 1 min - 1) and is not further inhibited by addi-
tion of excess e subunit. 
An additional and important indication of the improved 
purity of ECFi from the cytochrome Ao-deficient strain is 
our recent success in obtaining 3D crystals of the enzyme. A 
typical crystal is shown in Fig. 2. These contain all five sub-
units (a, |3, y, 8 and e) in the same stoichiometries as in the 
starting isolated enzyme, based on SDS polyacrylamide gels of 
dissolved crystals. They grow to a size of 0.5 X 0.4 X 0.2 mm 
within 6-8 weeks, are stable to X-ray radiation for at least 36 
h, and diffract to at least 6.4 A resolution (Fig. 3). Analysis of 
the diffraction data collected so far reveals an orthorhombic 
lattice with a = 110, 6=134 and c = 269 A, and a space group 
of P2i2i2i, assuming one molecule (molecular weight 380000) 
in the asymmetric unit gives a solvent content of 51.6% and a 
Vm of 2.56 A
3 per Da, which is well within the normal range 
of Vm values for protein crystals [27]. 
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